|
Current Status:
|
|
Board Member - Kern County Medical Society, 2005
|
|
Board Member - Bakersfield Heart Hospital, 2003-present
|
|
Private Practice, 1992-present
Central Cardiology Medical Clinic
Cardiac and Vascular Interventionalist
Consultative and General Cardiology
Nuclear Cardiology
|
|
Lead interventionalist for a large cardiology group. Practice includes heavy
emphasis on complex interventions including DCA, Excimer laser, Stent
Angioplasty and Peripheral Interventions.
|
|
Director Nuclear Lab conducting over 1400 annual nuclear studies.
|
|
Director of Cardiac Cath Laboratory - Bakersfield Heart Hospital, 1999-present
|
|
Chief of Staff - Central Cardiology Medical Clinic, 1999-present
|
|
Staff Cardiologist
Bakersfield Memorial Hospital, Bakersfield
San Joaquin Community Hospital, Bakersfield
Kern Medical Center, Bakersfield
Bakersfield Heart Hospital
|
|
Proctor for J & J intracoronary stents.
|
|
Proctor for Boston Scientific Rotablader Atherectomy
|
|
|
|
Certification and Licensure:
|
|
American Board of Internal Medicine, 2002, Interventional Cardiology
|
|
American Board of Internal Medicine, 2001, Cardiovascular Diseases
(Re-certification, 10TH Decile)
|
|
American Board of Internal Medicine, 1988
|
|
American Board of Internal Medicine (10TH Decile)
|
|
Cardiovascular Diseases, 1991 (10TH Decile)
|
|
Internal Medicine, 1984, Sri Guru Teg Bahadur Hospital, Amritsar, Punjab, India
|
|
|
|
Education:
|
|
1976-1980
MBBS
Guru Nanak Dev University
Jalandhar, Punjab, India
|
|
1974-1976
Pre-Medical
Guru Nanak Dev University
Jalandhar, Punjab, India
|
|
Postgraduate Training:
|
|
7/91 - 6/92
Chief Cardiac Cath Lab Fellow and Interventional Cardiology Fellow
Cedars-Sinai Medical Center
Los Angeles, CA
|
|
7/88 - 6/91
Fellowship, Cardiology
Michael Reese Hospital and Medical Center
Chicago, IL
|
|
7/89 - 6/90
Molecular Cardiology
University of Chicago
Chicago, IL
|
|
7/87 - 6/88
Residency, Internal Medicine
Lincoln Medical Center
New York Medical College
New York, NY
|
|
7/86 - 6/87
Internship, Internal Medicine
Lincoln Medical Center
New York Medical College
New York, NY
|
|
1/82 - 12/84
Residency, Internal Medicine
Sri Guru Teg Bahadur Hospital
Amritsar, Punjab, India
|
|
1/80 - 12/81
Internship, Internal Medicine
Sri Guru Teg Bahadur Hospital
Amritsar, Punjab, India
|
|
|
|
Examinations:
|
|
6/86 FLEX
|
|
7/85 FMGEMS
|
|
|
|
Awards:
|
|
The Alfred Pick-Richard Langendorf Award, 1990, Michael Reese Hospital (Awarded
to the most outstanding fellow)
|
|
|
|
Professional Memberships:
|
|
Member, Society for Cardiac Angiography and Intervention, 1994
|
|
Fellow, American College of Cardiology, 1994
|
|
Fellow, American College of Angiology, 1994
|
|
Member, California Medical Association, 1992
|
|
Member, Kern County Medical Society, 1992
|
|
|
|
Invited Lectures:
|
|
Excimer Laser Angioplasty: Follow up data on patients in ELCA Registry.
International Congress on Interventional Cardiology, Phoenix, Arizona. February
1992
|
|
Laser Update: Grand Rounds, Hoag Presbyterian Hospital, Newport Beach. April
1992
|
|
|
|
Publications:
|
|
Sharma S, Bhambi B. Successful treatment of hypotension associated with stunned
myocardium with oral midodrine therapy. J Cardiovasc Pharmacol Ther. 2005;10:
77-9.
|
|
Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft
administration of abciximab and verapamil combined with direct stenting
prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous
coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43
(abstract).
|
|
Sharma S, Bhambi B. Vertebral artery stenting utilizing distal embolic
protection withy Filter Wire and a drug eluting Taxus stent. (submitted)
|
|
Sharma S, Nyitray W, Bhambi B.Glycoprotein IIb/IIIa inhibition in percutaneous
coronary interventions. JAMA. 2003; 290:1451.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C,
Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may
predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
|
|
Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med
2002; 347: 1285.
|
|
Sharma S, Nyitray W, Bhambi B. Brachytherapy and saphenous vein grafts. N Engl
J Med 2002; 347: 692.
|
|
Sharma S, Bhambi B, Ishimori T. A better control for ICD patients? Eur Heart J
2002; 23:1972.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny
E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab
and verapamil combined with direct stenting prevents slow-flow during saphenous
vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
|
|
Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P,
Denny E. Delayed profound thrombocytopenia presenting 7 days after use of
abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002; 7(1):21-24.
|
|
B. Bhambi, M. Eghabali: Co-Regulation of Collagen Type 1 and Transforming
Growth Factor Beta in the Rat Ventricular Myocardium Following Increased
Arterial Blood Pressure Induced by Norepinephrine, American Journal of
Pathology, November 1991.
|
|
M. Eghabali, R. Tomek, R. Woods, B. Bhambi: Cardiac Fibroblasts Are Predisposed
to Transform into Myocytes: Specific Effects of Transforming Growth Factor Beta
1, Proc. Natl Aca Sci February 1991.
|
|
M. Eghabali, R. Tomek, V. Sukhatme, C. Woods, B. Bhambi: Differential Effects
of Transforming Growth Factor Beta and Phorbol Myristate Acetate on Cardiac
Fibroblasts: Regulation of Fibrillar Collagen mRNA's and Expression of
Immediate Early Growth Response Genes, Circulation Research, September 1991.
|
|
B. Bhambi, E. Morkin, S. Shroff, R. Tomek, J. Yao, M. Eghabali: Regulation of
Alpha and Beta Myosin Heavy Chain Gene Expression and the Induction of Early
Growth Response Genes in the Rat Ventricular Myocardium Following
Norepinephrine Treatment. (Manuscript Submitted)
|
|
|
|
Abstracts:
|
|
B. Bhambi, E. Morkin, S. Shroff, R. Tomek, M. Eghabali: Regulation of Alpha and
Beta Myosin Heavy Chain Gene Expression and the Induction of Early Growth
Response Gene 1 the Rat Myocardium Following Norepinephrine Treatment,
Circulation 1990; Vol 82, No. 4, 111-231, Oral Presentation, AHA, 1990 Dallas.
|
|
M. Eghabali, R. Tomek, C. Woods, B. Bhambi: Cardiac Fibroblasts Are Predisposed
To Transform Into Myocytes: Specific Effects of Transforming Growth Factor Beta
1, Journal of Cell Biology 1990, Vol.111, Number 5, Part 2.
|
|
M. Eghbali, R. Tomek, C. Woods, B. Bhambi: Differential Effects of Transforming
Growth Factor-Beta and Phorbol Myristate Acetate on Cardiac Fibroblasts:
Regulation of Fibrillar Collagen mRNA's and Expression of Immediate Early
Growth Response Genes, KEYSTONE 1991.
|
|
B. Bhambi, M. Eghbali: In Vivo Co-Regulation of Fibrillar Collagen Types 1 and
3, and Transforming Growth Factor Beta 1 Gee Expression in the Rat Myocardium.
FASEB, 1991.
|
|
|
|
DISCLAIMER: This web site and information is provided for general information
only and is not a substitute for professional medical advice. We are not
responsible or liable for any diagnosis or action made by a user based on the
content of this web site. |
© 2004 Central Cardiology Medical Clinic. All Rights Reserved. |
Tetsuo Ishimori, MD
